Brainsway Ltd.
Business
BrainsWay Ltd. is a medical device company that develops and commercializes Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform technology for treating psychiatric, neurological, and addiction disorders. The company's proprietary H-Coils deliver electromagnetic pulses to modulate brain activity, with FDA clearances for major depressive disorder, obsessive-compulsive disorder, and smoking addiction. BrainsWay generates revenue through fixed-fee leasing and direct sales of Deep TMS systems to psychiatrists' offices, hospitals, and medical centers, with most revenues from the United States and the remainder from international distributors and direct operations in Israel and other markets.
Summary from 20-F filed 2026-04-20
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $7.58M |
| Total assets | $113.19M |
| Total liabilities | — |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Brainsway Ltd.'s CIK number?
Brainsway Ltd.'s SEC CIK number is 0001505065 (1505065). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Brainsway Ltd.'s SEC filings?
All of Brainsway Ltd.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.